Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Feb 04, 2021 8:03am

90 Views

Post# 32468204

market depth

ecial terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @08:02:30

Bid			Ask
Broker	Size	Price	Price	Size	Broker
79 CIBC	10,000	0.49	0.49	8,000	7 TD Sec
7 TD Sec	1,500	0.49	0.49	9,000	79 CIBC
2 RBC	4,000	0.49	0.495	50,000	59 PI
1 Anonymous	20,000	0.49	0.495	10,000	85 Scotia
2 RBC	500	0.48	0.50	10,000	7 TD Sec
80 National Bank	4,000	0.48	0.50	500	7 TD Sec
7 TD Sec	40,000	0.47	0.51	8,000	124 Questrade
7 TD Sec	15,000	0.465	0.51	20,000	124 Questrade
1 Anonymous	1,000	0.455	0.51	1,500	80 National Bank
7 TD Sec	15,000	0.45	0.52	15,000	7 TD Sec